Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-004203
Filing Date
2025-01-16
Accepted
2025-01-16 18:00:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 26857
2 SCHEDULE A tm253593d1_ex-a.htm EX-99.1 8929
  Complete submission text file 0001104659-25-004203.txt   37606
Mailing Address 900 MIDDLESEX TURNPIKE BILLERICA MA 01821
Business Address 900 MIDDLESEX TURNPIKE BILLERICA MA 01821 617-301-9400
Quanterix Corp (Filed by) CIK: 0001503274 (see all company filings)

EIN.: 208957988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Subject) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92564 | Film No.: 25536580
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)